Stockhub

Mezzion Pharma Co.,Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 07:1607:16, 22 September 2022 95.149.241.133 talk 675 bytes +675 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Mezzion Pharma Co.,Ltd. engages in the development, licensing, and commercialization of drugs for the treatment of vascular diseases. It is developing Udenafil, a PDE5 inhibitor to treat erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension, overactive bladder, hepatic portal hypertension, and chronic obstructive pulmonary diseases. The company was formerly known as Dong-A Pharmtech Co., Ltd. a..."
Retrieved from "https://stockhub.co/research/Mezzion_Pharma_Co.,Ltd."